Analysis of TCGA data for copy number along with expression data where we correlated expression and copy number data, revealed a significant decrease in ZEB1 expression in both GBM and low grade glioma patients (Fig. 1b,c, P < 0.0001 and P = 0.0006 respectively). This evidence concerns the gene ZEB1 and glioblastoma.